Certificate of Analysis for Export: What Indian Exporters Need

A Certificate of Analysis for export is the same document as a domestic one — a batch-specific record of what was tested and what the results were — but more is riding on it, and more is usually asked of it. Importers commonly want the batch released against the pharmacopoeia of their market, a wider contaminant panel, and a set of supporting certificates that have nothing to do with the laboratory. The expensive mistakes almost always happen before manufacturing, not after.

What changes when the batch is going abroad

Nothing about the structure of the document changes. If you are not yet comfortable reading one, start with how to read a Certificate of Analysis — the anatomy is identical. What changes is the specification the batch is released against, and that is a decision made before the first kilogram of raw material is ordered.

• The pharmacopoeia. A domestic batch is typically released against Indian Pharmacopoeia methods. A buyer selling into a US or EU market will usually expect USP or EP methods, and the limits are not always identical. Agree this up front: retesting a finished batch against a different pharmacopoeia is expensive, and for some parameters it is not possible at all once the product is packed.
• A wider contaminant panel. Heavy metals and microbial limits are standard everywhere. Export buyers frequently add pesticide residues for botanicals, solvent residues for extracts, and allergen testing or declarations.
• Date formats and batch coding. Trivial until a customs officer reads 06/07/2026 as June and your paperwork says July. Agree an unambiguous format, and make sure the pack, the COA and the invoice all carry the same batch number in the same form.
• The nutritional panel. India declares % RDA per ICMR-NIN 2020. Other markets use their own references — a figure that is correct on an Indian label is simply the wrong number elsewhere. This is label work rather than COA work, but it is decided at the same moment.

The documents that travel with the COA

The COA proves the batch meets its specification. It does not prove the product is legal to sell, or that it came from where you say it did. Those are separate certificates, and which ones you need is decided by the destination country and the product category — not by your manufacturer.

Apply early. A finished batch waiting in a warehouse for a certificate is a common and entirely avoidable cost, and it eats the shelf life you are about to be asked to guarantee.

The shelf-life clause nobody reads until it bites

A COA does not expire — it describes a batch at the moment it was tested. What expires is the batch. Many importers require a minimum proportion of shelf life remaining when the goods clear customs, often expressed as a fraction such as 75%.

On a 24-month shelf life, a 75% clause means the batch must arrive within six months of manufacture. Add production, documentation, freight and customs, and the real window to ship after release can be quite short. Find out the number before you plan the batch size, because it determines how much you can safely make at once.

What to agree with your manufacturer before the first export batch

1. Which pharmacopoeia the batch is released against, named in the specification document.
2. The full test panel, including any contaminant tests the importer adds beyond the domestic standard.
3. Who pays for third-party testing, if the importer wants an independent laboratory as well as the manufacturer's own.
4. Retention samples — how long samples of the batch are kept, and whether you can draw on them if a query arises after shipment.
5. Which certificates the manufacturer obtains and which you obtain. Free Sale and health certificates are often assumed by both sides to be the other's job.
6. The minimum shelf life on dispatch, stated in writing and matched to your importer's clause.

These are the same instincts that apply to any manufacturing relationship — our guide to choosing a contract manufacturer covers the broader due diligence, and costs, MOQs and timelines covers what a realistic schedule looks like.

Red flags

• A manufacturer who agrees to an export specification without asking which market it is going to. The market determines the specification; agreeing before knowing it means nobody has thought about it.
• A "quality certificate" offered in place of a COA. If it has no batch number and no test results, it is not a COA, and it will not satisfy an importer.
• Any suggestion of adjusting a result to match a limit. Walk away immediately. A falsified COA is a documentary fraud that attaches to your brand in the destination market.
• Reluctance to name the laboratory, or to say whether testing was in-house or outsourced. Either is legitimate; being evasive about which is not.

Common questions

Is an export Certificate of Analysis different from a domestic one?

The document is the same thing — a batch-specific statement of what was tested and what the results were — but an export COA usually carries more. Importers commonly want testing against the pharmacopoeia of the destination market rather than the Indian one, a wider contaminant panel, and the manufacturing and expiry dates in a format their customs authority accepts. The structure does not change; the specification behind it does.

What other documents travel with an export shipment?

Typically a Certificate of Origin, a Free Sale Certificate or export no-objection certificate, and in many food and supplement markets a health certificate. Some destinations additionally require the documents to be apostilled or legalised. Which of these you need is decided by the destination country and the product category, so confirm with your importer and a customs broker before the batch is made, not after.

Who issues a Free Sale Certificate in India?

For food and nutraceutical products it is issued by FSSAI, and it states that the product is freely sold in India. It is one of the documents importers most often ask for, because it is their evidence that the product is not something India itself restricts. Apply for it with time to spare — it is a common cause of a finished batch sitting in a warehouse.

Should the COA test to IP, USP or EP?

Whichever the importer's market expects. Indian Pharmacopoeia methods are the default for domestic release, but a buyer in a US or EU market will usually want USP or EP methods, and the limits are not always identical. This has to be agreed before manufacturing, because it changes the specification the batch is released against — retesting a finished batch to a different pharmacopoeia is expensive and sometimes impossible.

How long should a COA be valid for an export shipment?

A COA does not expire, because it describes a batch at the time of testing. What matters is the batch's remaining shelf life on arrival. Many importers require a minimum proportion of shelf life remaining when the goods clear customs — often expressed as a fraction such as 75%. Agree that figure early, because it governs how quickly a batch must ship after release.